EDAP TMS S.A., each representing One Ordinary Share (EDAP): Price and Financial Metrics
EDAP TMS S.A., each representing One Ordinary Share (EDAP)
Today's Latest Price: $4.32 USD
Updated Sep 23 4:00pm
Add EDAP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 138 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
EDAP Stock Summary
- EDAP's current price/earnings ratio is 75.18, which is higher than 89.21% of US stocks with positive earnings.
- Price to trailing twelve month operating cash flow for EDAP is currently 32.57, higher than 89% of US stocks with positive operating cash flow.
- Over the past twelve months, EDAP has reported earnings growth of 88.01%, putting it ahead of 87.26% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to Edap Tms Sa, a group of peers worth examining would be DESP, AVNW, PERI, ITT, and VIVO.
- Visit EDAP's SEC page to see the company's official filings. To visit the company's web site, go to www.edap-tms.com.
EDAP Stock Price Chart Technical Analysis Charts
EDAP Price/Volume Stats
| Current price | $4.32 | 52-week high | $5.39 |
| Prev. close | $4.24 | 52-week low | $1.46 |
| Day low | $4.20 | Volume | 154,488 |
| Day high | $4.42 | Avg. volume | 111,622 |
| 50-day MA | $3.54 | Dividend yield | N/A |
| 200-day MA | $3.20 | Market Cap | 125.27M |
EDAP TMS S.A., each representing One Ordinary Share (EDAP) Company Bio
EDAP TMS S.A. develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases worldwide. The company was founded in 1979 and is based in Vaulx-en-Velin, France.
EDAP Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $4.32 | $2.73 | -36% |
We started the process of determining a valid price forecast for Edap Tms Sa with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Edap Tms Sa ranked in the 34th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 35.33%. As for the metrics that stood out in our discounted cash flow analysis of Edap Tms Sa, consider:
- The business' balance sheet reveals debt to be 7% of the company's capital (with equity being the remaining amount). Approximately only 17.54% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than merely 0% of stocks in its sector (Healthcare).
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -37% |
| 1% | -36% |
| 2% | -36% |
| 3% | -35% |
| 4% | -34% |
| 5% | -34% |
Want more companies with a valuation profile/forecast similar to that of Edap Tms Sa? See NVS, CAH, GILD, LMAT, and OSMT.
Loading social stream, please wait...